Xeris Biopharma Holdings, Inc.·4

Mar 29, 4:53 PM ET

Fairley Ricki Louise 4

4 · Xeris Biopharma Holdings, Inc. · Filed Mar 29, 2023

Insider Transaction Report

Form 4
Period: 2023-03-27
Transactions
  • Award

    Common Stock

    2023-03-27+85,00085,000 total
Footnotes (1)
  • [F1]These shares were acquired pursuant to a restricted stock unit award under the Company's 2018 Stock Option and Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock. These shares shall vest in equal annual installments over three years.

Documents

1 file
  • 4
    wf-form4_168012321668743.xmlPrimary

    FORM 4